imatinib mesylate has been researched along with Cancer of Sigmoid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Funahashi, W; Harada, A; Hasegawa, H; Ikeda, Y; Kabashima, A; Kitagawa, D; Kondo, N; Nakamura, T; Shoji, F; Teramoto, S | 1 |
1 other study(ies) available for imatinib mesylate and Cancer of Sigmoid
| Article | Year |
|---|---|
[No recurrent case of the combination of surgical management with chemotherapy].
Topics: Antineoplastic Agents; Benzamides; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Jejunal Neoplasms; Male; Middle Aged; Piperazines; Pyrimidines; Sigmoid Neoplasms; Tomography, X-Ray Computed | 2014 |